nodes	percent_of_prediction	percent_of_DWPC	metapath
Trilostane—HSD3B2—type 2 diabetes mellitus	0.807	1	CbGaD
Trilostane—Stanozolol—AR—type 2 diabetes mellitus	0.000815	0.134	CrCbGaD
Trilostane—Oxandrolone—AR—type 2 diabetes mellitus	0.000734	0.121	CrCbGaD
Trilostane—Drostanolone—SHBG—type 2 diabetes mellitus	0.000557	0.0914	CrCbGaD
Trilostane—Danazol—CCL2—type 2 diabetes mellitus	0.000528	0.0868	CrCbGaD
Trilostane—Drostanolone—AR—type 2 diabetes mellitus	0.000488	0.0802	CrCbGaD
Trilostane—Danazol—SHBG—type 2 diabetes mellitus	0.000301	0.0494	CrCbGaD
Trilostane—Danazol—AR—type 2 diabetes mellitus	0.000264	0.0433	CrCbGaD
Trilostane—Methyltestosterone—SHBG—type 2 diabetes mellitus	0.000254	0.0417	CrCbGaD
Trilostane—Methyltestosterone—AR—type 2 diabetes mellitus	0.000223	0.0366	CrCbGaD
Trilostane—Testosterone—CYP11A1—type 2 diabetes mellitus	0.000209	0.0344	CrCbGaD
Trilostane—Estradiol—SHBG—type 2 diabetes mellitus	0.000184	0.0302	CrCbGaD
Trilostane—Estradiol—AR—type 2 diabetes mellitus	0.000161	0.0265	CrCbGaD
Trilostane—Progesterone—SHBG—type 2 diabetes mellitus	0.000156	0.0256	CrCbGaD
Trilostane—Testosterone—SHBG—type 2 diabetes mellitus	0.000147	0.0242	CrCbGaD
Trilostane—Progesterone—AR—type 2 diabetes mellitus	0.000137	0.0224	CrCbGaD
Trilostane—Testosterone—AR—type 2 diabetes mellitus	0.000129	0.0212	CrCbGaD
Trilostane—Danazol—CYP3A4—type 2 diabetes mellitus	0.000104	0.017	CrCbGaD
Trilostane—Estradiol—CYP1A2—type 2 diabetes mellitus	9.56e-05	0.0157	CrCbGaD
Trilostane—Progesterone—NR3C1—type 2 diabetes mellitus	9.27e-05	0.0152	CrCbGaD
Trilostane—Methyltestosterone—CYP3A4—type 2 diabetes mellitus	8.76e-05	0.0144	CrCbGaD
Trilostane—Progesterone—CYP1A2—type 2 diabetes mellitus	8.12e-05	0.0133	CrCbGaD
Trilostane—Methyltestosterone—ALB—type 2 diabetes mellitus	7.64e-05	0.0125	CrCbGaD
Trilostane—Estradiol—CYP3A4—type 2 diabetes mellitus	6.33e-05	0.0104	CrCbGaD
Trilostane—Estradiol—ALB—type 2 diabetes mellitus	5.52e-05	0.00907	CrCbGaD
Trilostane—Progesterone—CYP3A4—type 2 diabetes mellitus	5.37e-05	0.00883	CrCbGaD
Trilostane—ESR1—Leptin signaling pathway—RELA—type 2 diabetes mellitus	5.22e-05	0.000279	CbGpPWpGaD
Trilostane—ESR2—SIDS Susceptibility Pathways—CASP3—type 2 diabetes mellitus	5.19e-05	0.000278	CbGpPWpGaD
Trilostane—ESR2—Generic Transcription Pathway—NOTCH2—type 2 diabetes mellitus	5.14e-05	0.000275	CbGpPWpGaD
Trilostane—ESR1—Generic Transcription Pathway—NCOA6—type 2 diabetes mellitus	5.12e-05	0.000274	CbGpPWpGaD
Trilostane—Testosterone—CYP3A4—type 2 diabetes mellitus	5.08e-05	0.00834	CrCbGaD
Trilostane—ESR1—Aryl Hydrocarbon Receptor—TNF—type 2 diabetes mellitus	5.06e-05	0.000271	CbGpPWpGaD
Trilostane—ESR2—Integrated Pancreatic Cancer Pathway—BCL2—type 2 diabetes mellitus	5.01e-05	0.000268	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	5.01e-05	0.000268	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—PSMD6—type 2 diabetes mellitus	4.99e-05	0.000267	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—SNAP25—type 2 diabetes mellitus	4.99e-05	0.000267	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—SREBF1—type 2 diabetes mellitus	4.99e-05	0.000267	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—PPARGC1A—type 2 diabetes mellitus	4.92e-05	0.000264	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—GNB3—type 2 diabetes mellitus	4.92e-05	0.000264	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—HMOX1—type 2 diabetes mellitus	4.9e-05	0.000263	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—CTGF—type 2 diabetes mellitus	4.9e-05	0.000263	CbGpPWpGaD
Trilostane—ESR2—Gene Expression—NCOA6—type 2 diabetes mellitus	4.89e-05	0.000262	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—AR—type 2 diabetes mellitus	4.87e-05	0.000261	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—HMGCR—type 2 diabetes mellitus	4.86e-05	0.00026	CbGpPWpGaD
Trilostane—ESR2—SIDS Susceptibility Pathways—NFKB1—type 2 diabetes mellitus	4.85e-05	0.00026	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—CAT—type 2 diabetes mellitus	4.84e-05	0.000259	CbGpPWpGaD
Trilostane—ESR2—Generic Transcription Pathway—AR—type 2 diabetes mellitus	4.8e-05	0.000257	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	4.79e-05	0.000257	CbGpPWpGaD
Trilostane—ESR2—Integrated Pancreatic Cancer Pathway—PTGS2—type 2 diabetes mellitus	4.76e-05	0.000255	CbGpPWpGaD
Trilostane—ESR1—Regulation of Telomerase—NFKB1—type 2 diabetes mellitus	4.76e-05	0.000255	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—ADRA2A—type 2 diabetes mellitus	4.75e-05	0.000255	CbGpPWpGaD
Trilostane—ESR1—AP-1 transcription factor network—MMP9—type 2 diabetes mellitus	4.7e-05	0.000252	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—APOB—type 2 diabetes mellitus	4.69e-05	0.000251	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—GSTM1—type 2 diabetes mellitus	4.57e-05	0.000245	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—CYP2E1—type 2 diabetes mellitus	4.57e-05	0.000245	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—SLC2A1—type 2 diabetes mellitus	4.52e-05	0.000242	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—CYP1A2—type 2 diabetes mellitus	4.52e-05	0.000242	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—CDKN2B—type 2 diabetes mellitus	4.49e-05	0.00024	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—LPL—type 2 diabetes mellitus	4.48e-05	0.00024	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—SIRT1—type 2 diabetes mellitus	4.44e-05	0.000238	CbGpPWpGaD
Trilostane—Testosterone—ALB—type 2 diabetes mellitus	4.43e-05	0.00728	CrCbGaD
Trilostane—ESR2—Generic Transcription Pathway—CDKN2B—type 2 diabetes mellitus	4.42e-05	0.000237	CbGpPWpGaD
Trilostane—ESR2—Integrated Pancreatic Cancer Pathway—CASP3—type 2 diabetes mellitus	4.42e-05	0.000237	CbGpPWpGaD
Trilostane—ESR2—SIDS Susceptibility Pathways—VEGFA—type 2 diabetes mellitus	4.41e-05	0.000236	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—CYP3A4—type 2 diabetes mellitus	4.4e-05	0.000236	CbGpPWpGaD
Trilostane—ESR1—Leptin signaling pathway—NFKB1—type 2 diabetes mellitus	4.4e-05	0.000236	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—ADCY5—type 2 diabetes mellitus	4.39e-05	0.000235	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	4.38e-05	0.000235	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—GPX1—type 2 diabetes mellitus	4.37e-05	0.000234	CbGpPWpGaD
Trilostane—ESR1—Integrated Breast Cancer Pathway—MMP1—type 2 diabetes mellitus	4.37e-05	0.000234	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—SLC2A4—type 2 diabetes mellitus	4.33e-05	0.000232	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—GCG—type 2 diabetes mellitus	4.33e-05	0.000232	CbGpPWpGaD
Trilostane—ESR1—Signaling by ERBB4—IRS2—type 2 diabetes mellitus	4.29e-05	0.00023	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—CD36—type 2 diabetes mellitus	4.26e-05	0.000228	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—PPP2CA—type 2 diabetes mellitus	4.21e-05	0.000225	CbGpPWpGaD
Trilostane—ESR2—Integrated Pancreatic Cancer Pathway—NFKB1—type 2 diabetes mellitus	4.13e-05	0.000221	CbGpPWpGaD
Trilostane—ESR1—Plasma membrane estrogen receptor signaling—AKT1—type 2 diabetes mellitus	4.13e-05	0.000221	CbGpPWpGaD
Trilostane—ESR1—Leptin signaling pathway—SRC—type 2 diabetes mellitus	4.1e-05	0.00022	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—MTHFR—type 2 diabetes mellitus	4.04e-05	0.000216	CbGpPWpGaD
Trilostane—ESR1—Regulation of Telomerase—TGFB1—type 2 diabetes mellitus	3.96e-05	0.000212	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—PPARA—type 2 diabetes mellitus	3.96e-05	0.000212	CbGpPWpGaD
Trilostane—ESR1—Regulation of Telomerase—EGFR—type 2 diabetes mellitus	3.89e-05	0.000208	CbGpPWpGaD
Trilostane—ESR2—Generic Transcription Pathway—NR3C1—type 2 diabetes mellitus	3.88e-05	0.000208	CbGpPWpGaD
Trilostane—ESR1—AP-1 transcription factor network—TGFB1—type 2 diabetes mellitus	3.87e-05	0.000207	CbGpPWpGaD
Trilostane—ESR2—Integrated Pancreatic Cancer Pathway—SRC—type 2 diabetes mellitus	3.85e-05	0.000206	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—AGT—type 2 diabetes mellitus	3.83e-05	0.000205	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—FAS—type 2 diabetes mellitus	3.81e-05	0.000204	CbGpPWpGaD
Trilostane—ESR2—SIDS Susceptibility Pathways—TNF—type 2 diabetes mellitus	3.78e-05	0.000202	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—CALM1—type 2 diabetes mellitus	3.77e-05	0.000202	CbGpPWpGaD
Trilostane—ESR1—Integrated Breast Cancer Pathway—IRS1—type 2 diabetes mellitus	3.77e-05	0.000202	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—APOE—type 2 diabetes mellitus	3.76e-05	0.000201	CbGpPWpGaD
Trilostane—ESR1—Signaling by ERBB4—IRS1—type 2 diabetes mellitus	3.75e-05	0.000201	CbGpPWpGaD
Trilostane—ESR2—Integrated Pancreatic Cancer Pathway—VEGFA—type 2 diabetes mellitus	3.75e-05	0.000201	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—GNB3—type 2 diabetes mellitus	3.73e-05	0.0002	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.73e-05	0.0002	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—APOA1—type 2 diabetes mellitus	3.71e-05	0.000199	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—HMOX1—type 2 diabetes mellitus	3.71e-05	0.000199	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—CAT—type 2 diabetes mellitus	3.66e-05	0.000196	CbGpPWpGaD
Trilostane—ESR2—Generic Transcription Pathway—PPARA—type 2 diabetes mellitus	3.63e-05	0.000195	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—APOB—type 2 diabetes mellitus	3.56e-05	0.000191	CbGpPWpGaD
Trilostane—ESR1—Integrated Breast Cancer Pathway—CASP8—type 2 diabetes mellitus	3.55e-05	0.00019	CbGpPWpGaD
Trilostane—ESR1—Generic Transcription Pathway—HNF4A—type 2 diabetes mellitus	3.49e-05	0.000187	CbGpPWpGaD
Trilostane—ESR1—Signaling by ERBB4—AKT2—type 2 diabetes mellitus	3.47e-05	0.000186	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—GSTM1—type 2 diabetes mellitus	3.46e-05	0.000185	CbGpPWpGaD
Trilostane—ESR2—Integrated Pancreatic Cancer Pathway—TGFB1—type 2 diabetes mellitus	3.44e-05	0.000184	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—LPL—type 2 diabetes mellitus	3.4e-05	0.000182	CbGpPWpGaD
Trilostane—ESR2—Integrated Pancreatic Cancer Pathway—EGFR—type 2 diabetes mellitus	3.37e-05	0.000181	CbGpPWpGaD
Trilostane—ESR1—ATF-2 transcription factor network—IL6—type 2 diabetes mellitus	3.34e-05	0.000179	CbGpPWpGaD
Trilostane—ESR2—Gene Expression—HNF4A—type 2 diabetes mellitus	3.33e-05	0.000178	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—ADCY5—type 2 diabetes mellitus	3.33e-05	0.000178	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—GPX1—type 2 diabetes mellitus	3.31e-05	0.000178	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—PPARG—type 2 diabetes mellitus	3.27e-05	0.000175	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—CD36—type 2 diabetes mellitus	3.23e-05	0.000173	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—ARAP1—type 2 diabetes mellitus	3.23e-05	0.000173	CbGpPWpGaD
Trilostane—ESR2—Integrated Pancreatic Cancer Pathway—TNF—type 2 diabetes mellitus	3.21e-05	0.000172	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—INS—type 2 diabetes mellitus	3.21e-05	0.000172	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—PPP2CA—type 2 diabetes mellitus	3.19e-05	0.000171	CbGpPWpGaD
Trilostane—ESR1—Signaling by ERBB4—PIK3R1—type 2 diabetes mellitus	3.15e-05	0.000169	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—MTHFR—type 2 diabetes mellitus	3.06e-05	0.000164	CbGpPWpGaD
Trilostane—ESR1—Integrated Breast Cancer Pathway—BCL2—type 2 diabetes mellitus	3.05e-05	0.000163	CbGpPWpGaD
Trilostane—ESR2—SIDS Susceptibility Pathways—IL6—type 2 diabetes mellitus	3.05e-05	0.000163	CbGpPWpGaD
Trilostane—ESR2—Generic Transcription Pathway—PPARG—type 2 diabetes mellitus	3e-05	0.000161	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—PPARA—type 2 diabetes mellitus	3e-05	0.000161	CbGpPWpGaD
Trilostane—ESR1—Generic Transcription Pathway—CTGF—type 2 diabetes mellitus	2.99e-05	0.00016	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—VPS26A—type 2 diabetes mellitus	2.95e-05	0.000158	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—CASP8—type 2 diabetes mellitus	2.94e-05	0.000158	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—ALB—type 2 diabetes mellitus	2.94e-05	0.000158	CbGpPWpGaD
Trilostane—ESR1—AP-1 transcription factor network—IL6—type 2 diabetes mellitus	2.92e-05	0.000156	CbGpPWpGaD
Trilostane—ESR2—Gene Expression—PSMD6—type 2 diabetes mellitus	2.91e-05	0.000156	CbGpPWpGaD
Trilostane—ESR2—Gene Expression—DNMT1—type 2 diabetes mellitus	2.91e-05	0.000156	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—AGT—type 2 diabetes mellitus	2.91e-05	0.000156	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—IGF1—type 2 diabetes mellitus	2.89e-05	0.000155	CbGpPWpGaD
Trilostane—ESR2—Gene Expression—CTGF—type 2 diabetes mellitus	2.86e-05	0.000153	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—CALM1—type 2 diabetes mellitus	2.86e-05	0.000153	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—APOE—type 2 diabetes mellitus	2.85e-05	0.000153	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—NOS3—type 2 diabetes mellitus	2.81e-05	0.000151	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—PIK3R1—type 2 diabetes mellitus	2.81e-05	0.000151	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—APOA1—type 2 diabetes mellitus	2.81e-05	0.000151	CbGpPWpGaD
Trilostane—ESR1—Regulation of Telomerase—AKT1—type 2 diabetes mellitus	2.75e-05	0.000148	CbGpPWpGaD
Trilostane—ESR2—Generic Transcription Pathway—SERPINE1—type 2 diabetes mellitus	2.71e-05	0.000145	CbGpPWpGaD
Trilostane—ESR1—Integrated Breast Cancer Pathway—CASP3—type 2 diabetes mellitus	2.69e-05	0.000144	CbGpPWpGaD
Trilostane—ESR1—Generic Transcription Pathway—NOTCH2—type 2 diabetes mellitus	2.59e-05	0.000139	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—PTGS2—type 2 diabetes mellitus	2.57e-05	0.000138	CbGpPWpGaD
Trilostane—ESR1—Leptin signaling pathway—AKT1—type 2 diabetes mellitus	2.55e-05	0.000136	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—BCL2—type 2 diabetes mellitus	2.53e-05	0.000135	CbGpPWpGaD
Trilostane—ESR1—Integrated Breast Cancer Pathway—NFKB1—type 2 diabetes mellitus	2.51e-05	0.000135	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—PPARG—type 2 diabetes mellitus	2.48e-05	0.000133	CbGpPWpGaD
Trilostane—ESR2—Gene Expression—NOTCH2—type 2 diabetes mellitus	2.48e-05	0.000133	CbGpPWpGaD
Trilostane—ESR1—Gene Expression—NCOA6—type 2 diabetes mellitus	2.46e-05	0.000132	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—INS—type 2 diabetes mellitus	2.43e-05	0.00013	CbGpPWpGaD
Trilostane—ESR1—Generic Transcription Pathway—AR—type 2 diabetes mellitus	2.42e-05	0.00013	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—PTGS2—type 2 diabetes mellitus	2.4e-05	0.000129	CbGpPWpGaD
Trilostane—ESR1—Regulation of nuclear SMAD2/3 signaling—AKT1—type 2 diabetes mellitus	2.39e-05	0.000128	CbGpPWpGaD
Trilostane—ESR2—Integrated Pancreatic Cancer Pathway—AKT1—type 2 diabetes mellitus	2.39e-05	0.000128	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—MTNR1A—type 2 diabetes mellitus	2.33e-05	0.000125	CbGpPWpGaD
Trilostane—ESR2—Gene Expression—AR—type 2 diabetes mellitus	2.31e-05	0.000124	CbGpPWpGaD
Trilostane—ESR1—Integrated Breast Cancer Pathway—VEGFA—type 2 diabetes mellitus	2.28e-05	0.000122	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—ALB—type 2 diabetes mellitus	2.23e-05	0.000119	CbGpPWpGaD
Trilostane—ESR1—Generic Transcription Pathway—CDKN2B—type 2 diabetes mellitus	2.23e-05	0.000119	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—CASP3—type 2 diabetes mellitus	2.23e-05	0.000119	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—PIK3R1—type 2 diabetes mellitus	2.13e-05	0.000114	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—NOS3—type 2 diabetes mellitus	2.13e-05	0.000114	CbGpPWpGaD
Trilostane—ESR2—Gene Expression—CDKN2B—type 2 diabetes mellitus	2.13e-05	0.000114	CbGpPWpGaD
Trilostane—ESR2—Gene Expression—SIRT1—type 2 diabetes mellitus	2.11e-05	0.000113	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—NFKB1—type 2 diabetes mellitus	2.08e-05	0.000112	CbGpPWpGaD
Trilostane—ESR1—Integrated Breast Cancer Pathway—EGFR—type 2 diabetes mellitus	2.05e-05	0.00011	CbGpPWpGaD
Trilostane—ESR1—Signaling by ERBB4—EGFR—type 2 diabetes mellitus	2.04e-05	0.000109	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—GCGR—type 2 diabetes mellitus	2.01e-05	0.000108	CbGpPWpGaD
Trilostane—ESR1—Generic Transcription Pathway—NR3C1—type 2 diabetes mellitus	1.96e-05	0.000105	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—PTGS2—type 2 diabetes mellitus	1.95e-05	0.000105	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—SRC—type 2 diabetes mellitus	1.94e-05	0.000104	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—type 2 diabetes mellitus	1.89e-05	0.000101	CbGpPWpGaD
Trilostane—ESR2—Gene Expression—NR3C1—type 2 diabetes mellitus	1.87e-05	0.0001	CbGpPWpGaD
Trilostane—ESR2—Gene Expression—PPP2CA—type 2 diabetes mellitus	1.86e-05	9.96e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—GRK5—type 2 diabetes mellitus	1.85e-05	9.93e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—GIPR—type 2 diabetes mellitus	1.85e-05	9.93e-05	CbGpPWpGaD
Trilostane—ESR1—Generic Transcription Pathway—PPARA—type 2 diabetes mellitus	1.83e-05	9.82e-05	CbGpPWpGaD
Trilostane—ESR2—Gene Expression—PPARA—type 2 diabetes mellitus	1.75e-05	9.37e-05	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—TGFB1—type 2 diabetes mellitus	1.73e-05	9.29e-05	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—EGFR—type 2 diabetes mellitus	1.7e-05	9.11e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—MC4R—type 2 diabetes mellitus	1.69e-05	9.08e-05	CbGpPWpGaD
Trilostane—ESR1—Gene Expression—HNF4A—type 2 diabetes mellitus	1.68e-05	9e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—GIP—type 2 diabetes mellitus	1.63e-05	8.74e-05	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—TNF—type 2 diabetes mellitus	1.62e-05	8.68e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling by ERBB4—IL6—type 2 diabetes mellitus	1.57e-05	8.41e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—LEPR—type 2 diabetes mellitus	1.55e-05	8.3e-05	CbGpPWpGaD
Trilostane—ESR1—Generic Transcription Pathway—PPARG—type 2 diabetes mellitus	1.51e-05	8.12e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—ATP2A3—type 2 diabetes mellitus	1.48e-05	7.94e-05	CbGpPWpGaD
Trilostane—ESR1—Gene Expression—DNMT1—type 2 diabetes mellitus	1.47e-05	7.87e-05	CbGpPWpGaD
Trilostane—ESR1—Gene Expression—PSMD6—type 2 diabetes mellitus	1.47e-05	7.87e-05	CbGpPWpGaD
Trilostane—ESR1—Integrated Breast Cancer Pathway—AKT1—type 2 diabetes mellitus	1.46e-05	7.8e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling by ERBB4—AKT1—type 2 diabetes mellitus	1.45e-05	7.75e-05	CbGpPWpGaD
Trilostane—ESR2—Gene Expression—PPARG—type 2 diabetes mellitus	1.45e-05	7.75e-05	CbGpPWpGaD
Trilostane—ESR1—Gene Expression—CTGF—type 2 diabetes mellitus	1.44e-05	7.72e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—TLE4—type 2 diabetes mellitus	1.44e-05	7.72e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—ADRB3—type 2 diabetes mellitus	1.39e-05	7.43e-05	CbGpPWpGaD
Trilostane—ESR1—Generic Transcription Pathway—SERPINE1—type 2 diabetes mellitus	1.36e-05	7.31e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—CRHR1—type 2 diabetes mellitus	1.34e-05	7.18e-05	CbGpPWpGaD
Trilostane—ESR2—Gene Expression—SERPINE1—type 2 diabetes mellitus	1.3e-05	6.98e-05	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—AKT1—type 2 diabetes mellitus	1.29e-05	6.93e-05	CbGpPWpGaD
Trilostane—ESR1—Gene Expression—NOTCH2—type 2 diabetes mellitus	1.25e-05	6.69e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—PRKAA1—type 2 diabetes mellitus	1.24e-05	6.62e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—SPRY2—type 2 diabetes mellitus	1.23e-05	6.56e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—MTNR1B—type 2 diabetes mellitus	1.23e-05	6.56e-05	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—AKT1—type 2 diabetes mellitus	1.21e-05	6.46e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—GLP1R—type 2 diabetes mellitus	1.19e-05	6.4e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—RBP4—type 2 diabetes mellitus	1.19e-05	6.4e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—CCKAR—type 2 diabetes mellitus	1.17e-05	6.29e-05	CbGpPWpGaD
Trilostane—ESR1—Gene Expression—AR—type 2 diabetes mellitus	1.16e-05	6.24e-05	CbGpPWpGaD
Trilostane—ESR1—Gene Expression—CDKN2B—type 2 diabetes mellitus	1.07e-05	5.75e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—ATP2A2—type 2 diabetes mellitus	1.06e-05	5.7e-05	CbGpPWpGaD
Trilostane—ESR1—Gene Expression—SIRT1—type 2 diabetes mellitus	1.06e-05	5.69e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—IAPP—type 2 diabetes mellitus	1.06e-05	5.67e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—INSR—type 2 diabetes mellitus	1.05e-05	5.63e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—TRPC6—type 2 diabetes mellitus	1.03e-05	5.53e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—AGTR2—type 2 diabetes mellitus	1.03e-05	5.5e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—EDNRB—type 2 diabetes mellitus	9.83e-06	5.27e-05	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—AKT1—type 2 diabetes mellitus	9.81e-06	5.25e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—PSMD6—type 2 diabetes mellitus	9.55e-06	5.11e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—HTR2C—type 2 diabetes mellitus	9.55e-06	5.11e-05	CbGpPWpGaD
Trilostane—ESR1—Gene Expression—NR3C1—type 2 diabetes mellitus	9.42e-06	5.04e-05	CbGpPWpGaD
Trilostane—ESR1—Gene Expression—PPP2CA—type 2 diabetes mellitus	9.37e-06	5.02e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—EDNRA—type 2 diabetes mellitus	9.29e-06	4.98e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—CYBA—type 2 diabetes mellitus	9.25e-06	4.95e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	9.09e-06	4.87e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—PLAT—type 2 diabetes mellitus	9.05e-06	4.85e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—GHRL—type 2 diabetes mellitus	9.05e-06	4.85e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—CALCA—type 2 diabetes mellitus	8.94e-06	4.79e-05	CbGpPWpGaD
Trilostane—ESR1—Gene Expression—PPARA—type 2 diabetes mellitus	8.82e-06	4.73e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	8.42e-06	4.51e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—PTPN1—type 2 diabetes mellitus	8.28e-06	4.43e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—GCG—type 2 diabetes mellitus	8.28e-06	4.43e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	8.14e-06	4.36e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	8.12e-06	4.35e-05	CbGpPWpGaD
Trilostane—ESR1—Gene Expression—PPARG—type 2 diabetes mellitus	7.29e-06	3.91e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	7.2e-06	3.86e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—GNB3—type 2 diabetes mellitus	7.13e-06	3.82e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—AVP—type 2 diabetes mellitus	7.04e-06	3.77e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—MMP3—type 2 diabetes mellitus	7.04e-06	3.77e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—IGF2—type 2 diabetes mellitus	7.01e-06	3.75e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	6.98e-06	3.74e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—APOB—type 2 diabetes mellitus	6.8e-06	3.64e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—IGF1R—type 2 diabetes mellitus	6.77e-06	3.63e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—EDN1—type 2 diabetes mellitus	6.69e-06	3.59e-05	CbGpPWpGaD
Trilostane—ESR1—Gene Expression—SERPINE1—type 2 diabetes mellitus	6.57e-06	3.52e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—LPL—type 2 diabetes mellitus	6.49e-06	3.48e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—ADCY5—type 2 diabetes mellitus	6.36e-06	3.41e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	6.09e-06	3.26e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—CCR5—type 2 diabetes mellitus	5.98e-06	3.21e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—C3—type 2 diabetes mellitus	5.85e-06	3.13e-05	CbGpPWpGaD
Trilostane—ESR2—Gene Expression—AKT1—type 2 diabetes mellitus	5.72e-06	3.06e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—HIF1A—type 2 diabetes mellitus	5.58e-06	2.99e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—IRS2—type 2 diabetes mellitus	5.56e-06	2.98e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—AGT—type 2 diabetes mellitus	5.56e-06	2.98e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—CALM1—type 2 diabetes mellitus	5.46e-06	2.93e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—APOE—type 2 diabetes mellitus	5.44e-06	2.92e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—LEP—type 2 diabetes mellitus	5.44e-06	2.92e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—APOA1—type 2 diabetes mellitus	5.38e-06	2.88e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—PRKCB—type 2 diabetes mellitus	5.13e-06	2.75e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—IRS1—type 2 diabetes mellitus	4.86e-06	2.6e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—INS—type 2 diabetes mellitus	4.65e-06	2.49e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—CCL2—type 2 diabetes mellitus	4.58e-06	2.45e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—IGF1—type 2 diabetes mellitus	4.5e-06	2.41e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—AKT2—type 2 diabetes mellitus	4.5e-06	2.41e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	4.27e-06	2.29e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—NOS3—type 2 diabetes mellitus	4.08e-06	2.19e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	4.08e-06	2.19e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—RELA—type 2 diabetes mellitus	3.84e-06	2.06e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—CASP3—type 2 diabetes mellitus	3.46e-06	1.86e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—MMP9—type 2 diabetes mellitus	3.27e-06	1.75e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	3.24e-06	1.73e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—SRC—type 2 diabetes mellitus	3.02e-06	1.62e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	2.94e-06	1.57e-05	CbGpPWpGaD
Trilostane—ESR1—Gene Expression—AKT1—type 2 diabetes mellitus	2.88e-06	1.54e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	2.7e-06	1.44e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—EGFR—type 2 diabetes mellitus	2.64e-06	1.42e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—IL6—type 2 diabetes mellitus	2.03e-06	1.09e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.87e-06	1e-05	CbGpPWpGaD
